Memphis Cancer Center — Memphis, Tennessee

Memphis Cancer Center is a clinical research site located in Memphis, Tennessee, United States 38119.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Memphis Cancer Center has participated in 7 clinical trials.

Therapeutic areas: Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer.

Sponsors: Sanofi, Novartis, Prologue Research International.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memphis Cancer Center?

Memphis Cancer Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memphis Cancer Center conducted?

Memphis Cancer Center has 7 clinical trials on record. Their work covers Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer.

Is Memphis Cancer Center accredited by Crixeo Health?

Yes — Memphis Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Memphis Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.